Published in J Cardiovasc Pharmacol on January 01, 1985
Antioxidant power of angiotensin-converting enzyme inhibitors in vitro. Br J Clin Pharmacol (1998) 0.96
Clinical pharmacology of the ACE inhibitors. Drugs (1986) 0.91
Effects of in vitro addition of captopril on copper-induced low density lipoprotein oxidation. Br J Clin Pharmacol (1995) 0.79
Ferrous sulphate interacts with captopril. Br J Clin Pharmacol (1998) 0.77
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci (2000) 1.74
Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med (1994) 1.69
Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes (1999) 1.65
Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients. Br J Clin Pharmacol (1984) 1.53
Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism. Acta Med Scand (1979) 1.49
Pharmacokinetics of N-acetylcysteine in man. Eur J Clin Pharmacol (1986) 1.45
Assessment of renal function in workers previously exposed to cadmium. Br J Ind Med (1985) 1.43
Controlled study of atenolol in treatment of hypertension. Br Med J (1975) 1.41
Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo. Oncogene (2007) 1.36
Pharmacokinetics of intravenous 2-mercaptopropionylglycine in man. Eur J Clin Pharmacol (1990) 1.34
Pharmacokinetics of oral tiopronin. Eur J Clin Pharmacol (1993) 1.33
Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs (2001) 1.33
Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant (1997) 1.33
Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study Group. Scand J Urol Nephrol (1998) 1.30
A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater Med Devices Artif Organs (1983) 1.25
beta 2-Microglobulinuria among workers previously exposed to cadmium: follow-up and dose-response analyses. Am J Ind Med (1985) 1.23
ATP is required for in vitro assembly of MHC class I antigens but not for transfer of peptides across the ER membrane. Cell (1991) 1.23
A comparison of the antihypertensive effect of atenolol (ICI 66 082) and propranolol. Eur J Clin Pharmacol (1976) 1.21
Spontaneous systemic lupus erythematosus and acelylator phenotype. Acta Med Scand (1977) 1.19
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol Dial Transplant (1994) 1.17
Neuroendocrine response in acute heart failure and the influence of treatment. Eur Heart J (1989) 1.16
Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients. Eur J Cancer (2003) 1.16
Canine cystinuria: an extended study on the effects of 2-mercaptopropionylglycine on cystine urolithiasis and urinary cystine excretion. Br Vet J (1993) 1.13
Pharmacokinetics and effects of frusemide in patients with the nephrotic syndrome. Eur J Clin Pharmacol (1989) 1.12
Primary fibromyalgia. A clinical and laboratory study of 55 patients. Scand J Rheumatol (1986) 1.11
Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood (1998) 1.11
Urinary excretion of amino acids in normal and cystinuric dogs. Br Vet J (1993) 1.10
Active oxygen induced DNA strand breakage and poly ADP-ribosylation in promotable and non-promotable JB6 mouse epidermal cells. Carcinogenesis (1988) 1.07
Bicarbonate and bicarbonate/lactate peritoneal dialysis solutions for the treatment of infusion pain. Kidney Int (1998) 1.07
Corticotropin, cortisol and beta-endorphin responses to the human corticotropin-releasing hormone during melancholia and after unilateral electroconvulsive therapy. Acta Psychiatr Scand (1990) 1.06
Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles. Br J Cancer (2005) 1.05
The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Br J Clin Pharmacol (1982) 1.04
Reciprocal inhibition during the tonic stretch reflex in the decerebrate cat. J Physiol (1978) 1.04
Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance. Br J Cancer (1996) 1.03
Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension. Clin Cardiol (2004) 1.02
Pharmacokinetic models for the saturable distribution of paclitaxel. Drug Metab Dispos (1999) 1.02
The effects of cimetidine (Tagamet) on renal function in patients with renal failure. Acta Med Scand (1980) 1.01
Evaluation of the sulphapyridine acetylator phenotyping test in healthy subjects and in patients with cardiac and renal diseases. Acta Med Scand (1977) 1.01
The effect of cimetidine, a new histamine H2-receptor antagonist, on renal function. Acta Med Scand (1979) 1.01
A new in vitro model to study interaction between whole blood and biomaterials. Studies of platelet and coagulation activation and the effect of aspirin. Biomaterials (1999) 0.99
Short- and long-term treatment with cimetidine in peptic ulcer disease and the pharmacokinetics of cimetidine. Scand J Gastroenterol Suppl (1979) 0.98
Nutritional assessment and clinical course in 112 elective surgical patients. Acta Chir Scand (1983) 0.98
UVB irradiation induces melanocyte increase in both exposed and shielded human skin. J Invest Dermatol (1989) 0.98
Glycemic control and prognosis in type I diabetic patients with microalbuminuria. Diabetes Care (1996) 0.98
Differential anti-inflammatory and anti-oxidative effects of dexamethasone and N-acetylcysteine in endotoxin-induced lung inflammation. Clin Exp Immunol (2000) 0.98
Once-daily metoprolol in primary hypertension. Clin Pharmacol Ther (1979) 0.97
CHS 828, a novel pyridyl cyanoguanidine with potent antitumor activity in vitro and in vivo. Cancer Res (1999) 0.97
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients. J Hypertens (2001) 0.96
Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients. Respir Med (2002) 0.95
End-stage chronic renal failure due to total uterine prolapse. Acta Obstet Gynecol Scand (1982) 0.95
Pitfalls in Doppler evaluation of diastolic function: insights from 3-dimensional magnetic resonance imaging. J Am Soc Echocardiogr (1999) 0.95
Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. J Hypertens (1994) 0.95
Regression of left ventricular hypertrophy in human hypertension with irbesartan. J Hypertens (2001) 0.95
Prizidilol, an antihypertensive with precapillary vasodilator and beta-adrenoceptor blocking actions, in primary hypertension. Clin Pharmacol Ther (1981) 0.94
Contact between a polymer and whole blood: sequence of events leading to thrombin generation. J Lab Clin Med (2001) 0.94
Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosis. Am J Med (1984) 0.94
The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications. Clin Exp Allergy (2007) 0.94
Salivary cortisol--an alternative to serum cortisol determinations in dynamic function tests. Clin Chem Lab Med (1998) 0.94
Increased plasma homocysteine levels without signs of vitamin B12 deficiency in patients with multiple sclerosis assessed by blood and cerebrospinal fluid homocysteine and methylmalonic acid. Mult Scler (2003) 0.94
Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model. J Clin Immunol (1996) 0.94
Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome? Leukemia (2000) 0.93
Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur J Cancer (1996) 0.93
A general model for time-dissociated pharmacokinetic-pharmacodynamic relationship exemplified by paclitaxel myelosuppression. Clin Pharmacol Ther (1998) 0.93
Overview of the clinical efficacy of investigational anticancer drugs. J Intern Med (2003) 0.93
SDZ PSC-833--a novel potent in vitro chemosensitizer in multiple myeloma. Anticancer Drugs (1992) 0.93
Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency. J Am Soc Nephrol (1998) 0.92
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors. Semin Oncol (1995) 0.92
Intestinal microsporidiosis in a HIV-seronegative patient. Scand J Infect Dis (1998) 0.91
Relationships between blood pressure, age, plasma renin activity and electrolyte excretion in normotensive subjects. Scand J Clin Lab Invest (1977) 0.91
Screening of an elderly female population for hypo- and hyperthyroidism by use of a thyroid hormone panel. Acta Med Scand (1983) 0.91
Atrial natriuretic peptide in pregnant and lactating goats. Acta Endocrinol (Copenh) (1989) 0.91
Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin. J Intern Med (2002) 0.90
Plasma and urinary aldosterone and their interrelations with blood pressure, plasma renin activity and urinary electrolytes in normotensive subjects. Scand J Clin Lab Invest (1978) 0.90
Long-term hypotensive effect of atenolol (ICI 66.082), a new beta-adrenergic blocking agent. Acta Med Scand (1976) 0.90
Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA). Gynecol Oncol (1994) 0.90
Cytotoxic activity of calcein acetoxymethyl ester (Calcein/AM) on primary cultures of human haematological and solid tumours. Eur J Cancer (1996) 0.89
Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic. Eur J Cancer (1999) 0.89
Synergistic interactions of combinations of topotecan with standard drugs in primary cultures of human tumor cells from patients. Eur J Clin Pharmacol (1998) 0.89
Binding of a model regulator of complement activation (RCA) to a biomaterial surface: surface-bound factor H inhibits complement activation. Biomaterials (2001) 0.89
Captopril, an orally active converting enzyme inhibitor, in the treatment of primary hypertension. A controlled long-term study with reference to initial plasma renin activity. Acta Med Scand (1981) 0.89
Development of vincristine resistance and increased sensitivity to cyclosporin A and verapamil in the human U-937 lymphoma cell line without overexpression of the 170-kDa P-glycoprotein. Int J Cancer (1994) 0.89
Guanidino-containing drugs in cancer chemotherapy: biochemical and clinical pharmacology. Biochem Pharmacol (2001) 0.89
Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators. Int J Cancer (1991) 0.89
Early identification of permanent myocardial damage after coronary surgery is aided by repeated measurements of CK-MB. Scand Cardiovasc J (2002) 0.88
Clinical and biochemical effects of spironolactone administered once daily in primary hypertension. Multicenter Sweden study. Hypertension (1980) 0.88
Endothelin induces an initial increase in cardiac output associated with selective vasodilation in rats. Life Sci (1989) 0.88
1,25(OH)2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcif Tissue Int (1988) 0.88
Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma. Int J Cancer (1996) 0.88
Titanium is a highly thrombogenic biomaterial: possible implications for osteogenesis. Thromb Haemost (1999) 0.88
Oxidants stress induces the proto-oncogenes, C-fos and C-myc in mouse epidermal cells. Bull Cancer (1990) 0.87
Cyclic adenosine 3',5'-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyper- and hypothyroidism. J Clin Endocrinol Metab (1974) 0.87
Effects of lovastatin on a human myeloma cell line: increased sensitivity of a multidrug-resistant subline that expresses the 170 kDa P-glycoprotein. Anticancer Drugs (1994) 0.87